Mesoblast (MESO) Acquisitions (2019 - 2025)
Mesoblast (MESO) posted quarterly Acquisitions of $161.6 million for Q2 2025, up 617.4% on a QoQ basis from $22.5 million in Q2 2023.
Mesoblast (MESO) Acquisitions (2019 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Acquisitions for 6 consecutive years, with $161.6 million the latest figure, recorded in Q2 2025.
- Quarterly Acquisitions changed N/A year-over-year to $161.6 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $215.0 million (changed N/A YoY) and the FY2025 annual result came in at $161.6 million, up 156.59% from the prior year.
- Acquisitions improved to $161.6 million in Q2 2025 per MESO's latest filing, from $22.5 million in the prior quarter.
- Over the last five years, Acquisitions for MESO reached as high as $161.6 million in Q2 2025 and fell as low as -$17.9 million in Q4 2022.
- A 4-year average of $70.9 million and a median of $81.1 million in 2022 frame the typical range for Acquisitions.
- Annual changes were most pronounced in 2022 — Acquisitions sank 118.85% — and 2023, when it surged 238.04%.
- Year by year, Acquisitions stood at $94.8 million in 2021, then plunged by 118.85% to -$17.9 million in 2022, then jumped by 225.92% to $22.5 million in 2023, then soared by 617.4% to $161.6 million in 2025.
- According to Business Quant data, Acquisitions over the past three periods registered $161.6 million, $22.5 million, and $48.8 million for Q2 2025, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 161.55 Mn |
| Jun 30, 2023 | 22.52 Mn |
| Mar 31, 2023 | 48.80 Mn |
| Dec 31, 2022 | -17.88 Mn |
| Sep 30, 2022 | 85.50 Mn |
| Jun 30, 2022 | -16.31 Mn |
| Mar 31, 2022 | 76.76 Mn |
| Dec 31, 2021 | 94.85 Mn |
| Sep 30, 2021 | 115.96 Mn |
| Jun 30, 2021 | 136.88 Mn |
| Sep 30, 2020 | 108.12 Mn |
| Jun 30, 2020 | 129.33 Mn |
| Sep 30, 2019 | 34.54 Mn |
| Jun 30, 2019 | 50.43 Mn |